Charlotte Kirby Charlotte Kirby

Axol Bioscience and Censo Biotechnologies announce merger

Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, today announced that the two companies have signed a merger agreement.

Read More
Charlotte Kirby Charlotte Kirby

Could a new treatment for diabetic eye disease be on the horizon?

Academics from the University of Bristol have contributed to the development of a potential treatment for Diabetic Macular Oedema (DMO); an eye condition affecting more than 20 million diabetes patients. This potentially game-changing drug has now reached the clinical trial stage and will be tested on 48 patient volunteers.

Read More
Charlotte Kirby Charlotte Kirby

Sorex Sensors founder honoured in Nova 111 global talent list

Dr Mario de Miguel Ramos, founder and CEO of University of Cambridge spin-out Sorex Sensors, has been named in the Nova 111 global talent list – which aims to recognise the “brightest stars” under 35. He features in the tech category of the list for his home country of Spain.

Read More
Charlotte Kirby Charlotte Kirby

Antiverse raises £1.4 million to advance its AI antibody drug discovery platform

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding totalling £1.4 million ($2 million USD), comprising new investment and match funding from the UKI2S Innovate Accelerator. The funding will be used to further develop Antiverse’s AI antibody drug discovery platform, which rapidly and accurately predicts antibody-antigen binding to identify antibody drug candidates.

Read More